Hypoxia-inducible factor 1α/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis

Neuropathology and Applied Neurobiology

Volumn 30, Issue 3, 2004, Pages 267-278

  Korkolopoulou, P ^a,b   Patsouris, E ^a   Konstantinidou, A E ^a   Pavlopoulos, P M ^a   Kavantzas, N ^a   Boviatsis, E ^a   Thymara, I ^a   Perdiki, M ^a   Thomas Tsagli, E ^a   Angelidakis, D ^a   Rologis, D ^a   Sakkas, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Astrocytoma; HIF 1 ; Proliferation; Survival; VEGF

Indexed keywords

FIBRINOGEN; KI 67 ANTIGEN; PROTEIN P53; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CELL PROLIFERATION; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MORPHOMETRICS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CAPILLARIES; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGIONAL BLOOD FLOW; REPRESSOR PROTEINS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2942707871     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2003.00535.x     Document Type: Article

References (47)

1. Folkman J. Tumour angiogenesis: therapeutic implications. N Engl J Med 1971; 2851: 1182-6
2. 2 gradients in solid tumours in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3: 177-82
3. Dor Y, Keshet E. Oxygen and tumour angiogenesis. In Angiogenesis in Health and Disease. Ed. GM Rubanyi. New York: Marcel Dekker Inc., 2000; 245-60
4. 2 tension. Am J Physiol 1996; 271: 01172-80
5. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551-78
6. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230-7
7. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95: 7987-92
8. Wenger RH, Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 1997; 378: 609-16
9. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circ Res 1995; 77: 638-43
10. Abdulrauf SL, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998; 88: 513-20
11. Bian XW, Du LL, Shi JQ, Cheng YS, Liu FX. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. Anal Quant Cytol Histol 2000; 22: 267-74
12. Korkolopoulou P, Patsouris E, Kavantzas N, Konstan-tinidou AE, Christodoulou P, Thomas-Tsagli E, Papanikolaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, Rologis D, Davaris P. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 2002; 28: 57-66
13. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumours. Cancer 1996; 77: 362-72
14. Li VW, Folkerth RD, Watanabe H, Yu C, Rupniek M, Barnes P, Scott PM, Black PM, Sallan SE, Folkman J. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 1994; 344: 82-6
15. Sondergaard KL, Hilton DA, Penney M, Ollerenshaw M, Demaine AG. Expression of hypoxia-inducible factor 1α in tumours of patients with glioblastoma. Neuropathol Appl Neuroblol 2002; 28: 210-17
16. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL. Expression of hypoxia-inducible factor 1α in brain tumours. Association with angiogenesis, invasion and progression. Cancer 2000; 88: 2606-18
17. Cavenee WK, Furnari FB, Nagane M, Huang H-JS, Newcomb EW, Bigner DD, Weller M, Berens ME, Plate KH, Israel MA, Noble MD, Kleihues P. Diffusely infiltrating astrocytomas. In Pathology and Genetics of Tumours of the Nervous System. Eds P Kleihues, W K Cavenee. Lyon: IARC Press, 2000: 10-21
18. Pietch T, Valter MM, Wolf HK, von Deimling A, Su Huang H-J, Cavenee WK, Wiestler OD. Expression and distribution of vascular endothelial growth factor protein in human brain tumours. Acta Neuropathol 1997; 9: 109-17
19. Zhong H, DeMarzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5
20. De Paola F, Granata AM, Scarpi E, Monti F, Medri L, Bianchi S, Amadori D, Volpi A. Vascular endothelial growth factor and prognosis in patients with node-negative breast cancer. Int J Cancer 2002; 98: 228-33
21. Brem S. The role of vascular proliferation in the growth of brain tumours. Clin Neurosurg 1976; 223: 440-53
22. Folkerth RD. Descriptive analysis and quantification of angiogenesis in human brain tumours. J Neurooncol 2000; 50: 165-72
23. Scherrer HJ. Gliomstudien XX III. Angioplastische glioma. Virchows Arch 1935; 294: 823-61
24. Brat DJ, Van Meir EG. Glomeruloid microvascular proliferation orchestrated by VPF/VEGF. A new world of angiogenesis research. Am J Pathol 2001; 158: 789-96
25. Machein MR, Plate KH. VEGF in brain tumours. J Neurooncol 2000; 50: 109-20
26. Chaudhry IH, O'Donovan DG, Brenchley DEC, Reid H, Roberts ISD. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 2001; 39: 409-15
27. Oehring RD, Miletic M, Valter MM, Pietsch T, Neumann J, Fimmers R, Schlegel U. Vascular endothelial growth factor (VEGF) in astrocytic gliomas - a prognostic factor? J Neuro-Oncol 1999; 45: 117-25
28. Yao Y, Kubota T, Sato K, Kitai R, Takeuchi H, Arishima H. Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours. Acta Neurochir (Wien) 2001; 143: 159-66
29. Forsythe JA, Jiang B-H, Iyer NV, Agani F, Leung SW, Koos RD. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-13
30. Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996; 271: 2746-53
31. 2 homeostasis by hypoxia-inducible factor 1a. Genes Dev 1998; 12: 149-62
32. Plate KH, Breier G, Weich HA, Mennel HD, Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994; 59: 520-9
33. Birner P, Gatterbauer B, Oberhuber G, Schindl M, Rössler K, Prodinger A, Budka H, Hainfellner JA. Expression of hypoxia-inducible factor-1a in oligodendrogliomas, Its impact on prognosis and on neoangiogenesis. Cancer 2001; 92: 165-71
34. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny M, Neckers LM. Stabilisation of wild-type p53 by hypoxia-inducible factor-1a. Nature 1998; 392: 405-8
35. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ Jr, Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a G1 phase checkpoint by low oxygen conditions is independent of p53 status. Mol Cell Biol 1994; 14: 6264-77
36. Drake CJ, Little CD. VEGF and vascular fusion: implications for normal and pathological vessels. J Histochem Cytochem 1999; 47: 1351-6
37. Xie B, Tam NN, Tsao SW, Wong YC. Coexpression of vascular endothelial growth factor (VEGF) and its receptors (Flk-1 and flk-1) in hormone-induced mammary cancer in the Noble rat. Br J Cancer 1999; 81: 1335-43
38. Von Marschall Z, Cramer T, Hocker M, Burde R, Plath T, Schirner M, Heidenreich R, Breier G, Riecken EO, Wiedenmann B, Rosewicz S. De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop. Gastroenterology 2000; 119: 1358-72
39. Shaheen RM, Tseng WW, Vellagas R, Liu W, Ahmad SA, Jung YD, Reinmuth N, Drazan KE, Bucana CD, Hicklin DJ, Ellis LM. Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumour vascularity and apoptosis in a murine model of colon carcinomatosis. Int J Oncol 2001; 18: 221-6
40. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit J, Johnson RS. Hypoxia-inducible factor-1a is a positive factor in solid tumour growth. Cancer Res 2000; 60: 4010-15
41. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Neeman M, Bono F, Abramovich R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshet E. Role of HIF-1 alpha in hypoxia mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-90
42. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. The expression and distribution of the hypoxia inducible factors HIF-1α and HIF-2α in normal human tissues, cancers and tumor associated macrophages. Am J Pathol 2000; 157: 411-21
43. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH, Semenza GL. Expression of hypoxia-inducible factor-1a: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61: 2911-16
44. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1α in epithelial ovarian tumours: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2000; 7: 1661-8
45. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early stage invasive cervical cancer. Cancer Res 2000; 60: 4693-6
46. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G, the Austrian Breast and Colorectal Cancer Study Group. Overexpression of hypoxia-induced factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002; 8: 1831-7
47. Moulder JE, Rockwell S. Tumour hypoxia: its impact on cancer therapy. Cancer Metastasis Rev 1987; 5: 313-41